As the U.S. stock market experiences a surge, with the S&P 500 on track for its longest winning streak since 2004, investors are closely watching growth companies that insiders are eager to hold onto. In such a buoyant market environment, stocks with high insider ownership can signal confidence in their future prospects and stability amidst economic uncertainties.
Top 10 Growth Companies With High Insider Ownership In The United States
| Name | Insider Ownership | Earnings Growth |
| Super Micro Computer (NasdaqGS:SMCI) | 14.1% | 34.1% |
| Hims & Hers Health (NYSE:HIMS) | 13.1% | 21.8% |
| Duolingo (NasdaqGS:DUOL) | 14.3% | 37.5% |
| Credo Technology Group Holding (NasdaqGS:CRDO) | 12.2% | 65.1% |
| Niu Technologies (NasdaqGM:NIU) | 36% | 82.8% |
| Astera Labs (NasdaqGS:ALAB) | 15.5% | 61.4% |
| Clene (NasdaqCM:CLNN) | 19.4% | 64% |
| Upstart Holdings (NasdaqGS:UPST) | 12.6% | 100.2% |
| BBB Foods (NYSE:TBBB) | 16.2% | 29.6% |
| CoreWeave (NasdaqGS:CRWV) | 38.3% | 70.3% |
Here's a peek at a few of the choices from the screener.
Niagen Bioscience (NasdaqCM:NAGE)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Niagen Bioscience, Inc. is a bioscience company focused on developing healthy aging products with a market cap of $611.65 million.
Operations: Niagen Bioscience generates revenue through its segments, which include Ingredients ($19.81 million), Consumer Products ($76.77 million), and Analytical Reference Standards and Services ($3.01 million).
Insider Ownership: 29.9%
Niagen Bioscience, recently rebranded from ChromaDex Corporation, is positioned for robust growth with a forecasted earnings increase of 32.16% annually over the next three years, outpacing the broader US market. The company has achieved profitability this year and expects revenue to grow at 16.8% per year. Niagen's extensive intellectual property portfolio in NAD+ precursors strengthens its competitive edge in the healthy aging sector. Recent insider activity shows more buying than selling, albeit not substantially so.
- Click here to discover the nuances of Niagen Bioscience with our detailed analytical future growth report.
- The analysis detailed in our Niagen Bioscience valuation report hints at an inflated share price compared to its estimated value.
Westrock Coffee (NasdaqGM:WEST)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Westrock Coffee Company, LLC is an integrated provider of coffee, tea, flavors, extracts, and ingredient solutions operating both in the United States and internationally with a market cap of $548.91 million.
Operations: The company's revenue is derived from two primary segments: Beverage Solutions, contributing $659.38 million, and Sustainable Sourcing & Traceability, generating $202.44 million.
Insider Ownership: 13.6%
Westrock Coffee's revenue growth is projected at 17.4% annually, surpassing the US market average. The company is expected to achieve profitability within three years, indicating strong growth potential. Recent financial results show a net loss increase year-over-year, but insider activity has been positive with substantial buying and no significant selling in the past three months. Analysts anticipate an 82.4% stock price rise despite high share price volatility and limited cash runway.
- Navigate through the intricacies of Westrock Coffee with our comprehensive analyst estimates report here.
- Insights from our recent valuation report point to the potential undervaluation of Westrock Coffee shares in the market.
trivago (NasdaqGS:TRVG)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: trivago N.V. operates a hotel and accommodation search platform across various international markets, including the United States, Germany, and Japan, with a market cap of approximately $292.77 million.
Operations: trivago N.V. generates revenue through its hotel and accommodation search platform, serving markets such as the United States, Germany, the United Kingdom, Canada, and Japan.
Insider Ownership: 19.6%
trivago N.V. is trading at a significant discount to its estimated fair value, suggesting potential upside. Recent corporate guidance raised expectations for mid-teens revenue growth in 2025, indicating strong momentum. Despite a net loss of €7.8 million in Q1 2025, sales increased to €124.11 million from the previous year. The company forecasts profitability within three years, although share price volatility remains high and no substantial insider trading activity has been reported recently.
- Click here and access our complete growth analysis report to understand the dynamics of trivago.
- The analysis detailed in our trivago valuation report hints at an deflated share price compared to its estimated value.
Key Takeaways
- Reveal the 199 hidden gems among our Fast Growing US Companies With High Insider Ownership screener with a single click here.
- Seeking Other Investments? The latest GPUs need a type of rare earth metal called Terbium and there are only 23 companies in the world exploring or producing it. Find the list for free.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Valuation is complex, but we're here to simplify it.
Discover if trivago might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com